Growth Metrics

Dexcom (DXCM) Cash from Investing Activities Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -50.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -397.90%
Dec 31, 2025 200.95%
Sep 30, 2025 -8.32%
Jun 30, 2025 66.33%
Mar 31, 2025 33.96%
Dec 31, 2024 -173.20%
Sep 30, 2024 217.16%
Jun 30, 2024 66.02%
Mar 31, 2024 140.06%
Dec 31, 2023 313.76%
Sep 30, 2023 -178.28%
Jun 30, 2023 -283.64%
Mar 31, 2023 54.66%
Dec 31, 2022 60.87%
Sep 30, 2022 690.69%
Jun 30, 2022 -139.90%
Mar 31, 2022 -267.02%
Dec 31, 2021 -1,967.08%
Sep 30, 2021 411.83%
Jun 30, 2021 132.57%
Mar 31, 2021 -185.91%
Dec 31, 2020 74.55%
Sep 30, 2020 97.75%
Jun 30, 2020 -74.43%
Mar 31, 2020 -0.53%
Dec 31, 2019 -405.18%
Sep 30, 2019 -9,073.91%
Jun 30, 2019 -299.87%
Mar 31, 2019 952.60%
Dec 31, 2018 2,909.09%
Sep 30, 2018 112.57%
Jun 30, 2018 -87.46%
Mar 31, 2018 28.04%
Dec 31, 2017 93.64%
Sep 30, 2017 -105.62%
Jun 30, 2017 -788.54%
Mar 31, 2017 -91.07%
Dec 31, 2016 -36.22%
Sep 30, 2016 -212.28%
Jun 30, 2016 -33.33%
Mar 31, 2016 56.76%
Dec 31, 2015 -170.21%
Sep 30, 2015 -50.00%
Jun 30, 2015 -80.00%
Mar 31, 2015 -502.33%
Dec 31, 2014 -1,040.00%
Sep 30, 2014 -323.53%
Jun 30, 2014 -165.57%
Mar 31, 2014 -134.13%
Dec 31, 2013 -92.42%
Sep 30, 2013 -51.43%
Jun 30, 2013 -7.58%
Mar 31, 2013 7.69%
Dec 31, 2012 289.93%
Sep 30, 2012 133.01%
Jun 30, 2012 116.88%
Mar 31, 2012 72.67%
Dec 31, 2011 82.98%
Sep 30, 2011 -244.70%